AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

List of Waystar Denial Prevention + Recovery Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Prosthetic And Orthotic Group Life Sciences 12 $2M United States Waystar Waystar Denial Prevention + Recovery Revenue Cycle Management 2021 n/a
In 2021, Prosthetic And Orthotic Group implemented Waystar Denial Prevention + Recovery. This was a Revenue Cycle Management deployment across a multi location outpatient revenue cycle and finance environment in the United States, focused on automating eligibility and claim status workflows and centralized monitoring of claims and denials. The implementation explicitly added Waystar Claim Monitoring and Denial & Appeal Management as core modules within Waystar Denial Prevention + Recovery, configuring automated eligibility checks, claim status polling, and denial triage workflows. The group reported an increase in first pass clean claims to 98 percent and accelerated denial workup by up to 30 days, outcomes captured directly from the deployment case study. The deployment included an integration with the Nymbl practice management system to exchange eligibility and claim status data, improving end to end visibility between practice management and the Revenue Cycle Management tooling. Operational coverage targeted outpatient billing and revenue cycle teams across multiple clinic sites, centralizing claim monitoring and appeal management workflows. Governance changes focused on reassigning denial queues and formalizing appeal orchestration within the new Denial & Appeal Management module, with automated routing and status tracking driving process standardization. The narrative centers on system architecture and operational scope, emphasizing the use of Waystar Denial Prevention + Recovery and named modules to streamline claims processing and denial resolution.
U.S. Digestive Health Healthcare 1250 $350M United States Waystar Waystar Denial Prevention + Recovery Revenue Cycle Management 2025 n/a
In 2025, U.S. Digestive Health implemented Waystar Denial Prevention + Recovery as part of a broader adoption of Waystar’s end to end platform. The deployment directly supports Revenue Cycle Management objectives across the organization, aligning revenue cycle and patient financial services under a single vendor suite. The implementation included Waystar Denial Prevention + Recovery alongside core Waystar modules such as Claim Management, Claim + Payer Payment Management, and Analytics + Reporting. Configuration emphasized automated denial detection and prevention workflows, bulk resubmission capabilities, and automated patient estimates to improve point of care financial counseling. The full application name Waystar Denial Prevention + Recovery is used operationally within daily claim workflows and patient payment orchestration. Operational coverage centers on the revenue cycle management organization, with the RCM leadership team and claims operations using Claim Management daily to prioritize work queues and drive payer engagement. Patient financial services benefitted from automated estimates so patients receive clear cost expectations before care, and back end tools surfaced gaps via analytics to focus remediation. Integrations remained internal to Waystar’s platform modules, preserving a unified data model for claims, denials, payments, and reporting. Governance was described as collaborative, with U.S. Digestive Health feeding operational feedback into iterative product improvements, and Waystar implementing changes that adjusted workflows and reduced manual effort. Reported outcomes include faster payments, lower operational cost of collections, improved patient experience through no surprise estimates, and fewer staff hours spent on weekly denial handling. This positions U.S. Digestive Health’s Waystar Denial Prevention + Recovery within Revenue Cycle Management to optimize reimbursement and patient financial transparency.
Vibra Healthcare, LLC Leisure and Hospitality 1500 $400M United States Waystar Waystar Denial Prevention + Recovery Revenue Cycle Management 2018 n/a
In 2018, Vibra Healthcare, LLC deployed Waystar Denial Prevention + Recovery as a U.S. revenue-cycle initiative within Revenue Cycle Management. The deployment targeted claims management with Denial & Appeal Management and claim-monitoring modules to automate appeals, convert paper EOBs to electronic workflows, and support denial prevention and recovery. Configuration centered on Waystar Denial Prevention + Recovery components for Denial & Appeal Management and claims management, enabling automated appeal generation and electronic ingestion of EOBs. The implementation embedded claim-monitoring capabilities to identify denial patterns and route cases for automated or manual appeal handling. The scope of the implementation covered Vibra Healthcare's revenue-cycle and finance functions across its U.S. operations, aligning billing operations and appeals workflows under a centralized denial prevention process. Governance changes emphasized standardized appeal protocols and operational ownership by revenue-cycle teams to accelerate claim review and recovery. Outcomes recorded in the case study include rebilling $12.8M in previously denied claims, achieving a 99.9% clean claims rate, and reducing staff time through automation of appeals and EOB conversion. Waystar Denial Prevention + Recovery served as the primary Revenue Cycle Management application for denial prevention and recovery within Vibra Healthcare's billing and finance processes.
Healthcare 2000 $240M United States Waystar Waystar Denial Prevention + Recovery Revenue Cycle Management 2017 n/a
Showing 1 to 4 of 4 entries

Buyer Intent: Companies Evaluating Waystar Denial Prevention + Recovery

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Waystar Denial Prevention + Recovery. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Waystar Denial Prevention + Recovery Coverage

Waystar Denial Prevention + Recovery is a Revenue Cycle Management solution from Waystar.

Companies worldwide use Waystar Denial Prevention + Recovery, from small firms to large enterprises across 21+ industries.

Organizations such as Vibra Healthcare, LLC, U.S. Digestive Health, Yuma and Prosthetic And Orthotic Group are recorded users of Waystar Denial Prevention + Recovery for Revenue Cycle Management.

Companies using Waystar Denial Prevention + Recovery are most concentrated in Leisure and Hospitality, Healthcare and Life Sciences, with adoption spanning over 21 industries.

Companies using Waystar Denial Prevention + Recovery are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Waystar Denial Prevention + Recovery across Americas, EMEA, and APAC.

Companies using Waystar Denial Prevention + Recovery range from small businesses with 0-100 employees - 25%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 75%, and global enterprises with 10,000+ employees - 0%.

Customers of Waystar Denial Prevention + Recovery include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Waystar Denial Prevention + Recovery customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Revenue Cycle Management.